Overview

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Clinical study to examine the efficacy, safety and tolerability of combination therapy of tamsulosin hydrochloride and solifenacin succinate compared to monotherapy of tamsulosin hydrochloride in the treatment of males with LUTS associated with BPH with a substantial storage component.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Europe B.V.
Treatments:
Solifenacin Succinate
Tamsulosin